These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 12901781

  • 1. Cognitive asymmetries associated with apolipoprotein E genotype in patients with Alzheimer's disease.
    Finton MJ, Lucas JA, Rippeth JD, Bohac DL, Smith GE, Ivnik RJ, Petersen RC, Graff-Radford NR.
    J Int Neuropsychol Soc; 2003 Jul; 9(5):751-9. PubMed ID: 12901781
    [Abstract] [Full Text] [Related]

  • 2. Cognitive impairment in Alzheimer's disease is modified by APOE genotype.
    van der Vlies AE, Pijnenburg YA, Koene T, Klein M, Kok A, Scheltens P, van der Flier WM.
    Dement Geriatr Cogn Disord; 2007 Jul; 24(2):98-103. PubMed ID: 17596691
    [Abstract] [Full Text] [Related]

  • 3. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.
    Hoyt BD, Massman PJ, Schatschneider C, Cooke N, Doody RS.
    Arch Neurol; 2005 Mar; 62(3):454-9. PubMed ID: 15767511
    [Abstract] [Full Text] [Related]

  • 4. APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model.
    Martins CA, Oulhaj A, de Jager CA, Williams JH.
    Neurology; 2005 Dec 27; 65(12):1888-93. PubMed ID: 16380608
    [Abstract] [Full Text] [Related]

  • 5. Apolipoprotein E and cognitive performance: a meta-analysis.
    Small BJ, Rosnick CB, Fratiglioni L, Bäckman L.
    Psychol Aging; 2004 Dec 27; 19(4):592-600. PubMed ID: 15584785
    [Abstract] [Full Text] [Related]

  • 6. [Dementia and cognitive impairment pattern: its association with epsilon4 allele of apolipoprotein E gene].
    Rosich-Estragó M, Figuera-Terré L, Mulet-Pérez B, Arrufat-Cardús MT, Pascual San Emeterio A, Arbeola-Rigau I, Labad-Alquézar A, Vilella-Cuadrada E.
    Rev Neurol; 2004 Dec 27; 38(9):801-7. PubMed ID: 15152345
    [Abstract] [Full Text] [Related]

  • 7. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
    Devanand DP, Pelton GH, Zamora D, Liu X, Tabert MH, Goodkind M, Scarmeas N, Braun I, Stern Y, Mayeux R.
    Arch Neurol; 2005 Jun 27; 62(6):975-80. PubMed ID: 15956169
    [Abstract] [Full Text] [Related]

  • 8. Apolipoprotein epsilon4 and neuropsychological performance in Alzheimer's disease and vascular dementia.
    McGuinness B, Carson R, Barrett SL, Craig D, Passmore AP.
    Neurosci Lett; 2010 Oct 08; 483(1):62-6. PubMed ID: 20678545
    [Abstract] [Full Text] [Related]

  • 9. Slower speed-of-processing of cognitive tasks is associated with presence of the apolipoprotein epsilon4 allele.
    O'Hara R, Sommer B, Way N, Kraemer HC, Taylor J, Murphy G.
    J Psychiatr Res; 2008 Feb 08; 42(3):199-204. PubMed ID: 17250852
    [Abstract] [Full Text] [Related]

  • 10. Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis.
    Kleiman T, Zdanys K, Black B, Rightmer T, Grey M, Garman K, Macavoy M, Gelernter J, van Dyck C.
    Dement Geriatr Cogn Disord; 2006 Feb 08; 22(1):73-82. PubMed ID: 16699282
    [Abstract] [Full Text] [Related]

  • 11. Most rapid cognitive decline in APOE epsilon4 negative Alzheimer's disease with early onset.
    van der Vlies AE, Koedam EL, Pijnenburg YA, Twisk JW, Scheltens P, van der Flier WM.
    Psychol Med; 2009 Nov 08; 39(11):1907-11. PubMed ID: 19335933
    [Abstract] [Full Text] [Related]

  • 12. Apolipoprotein E epsilon4 allele differentiates the clinical response to donepezil in Alzheimer's disease.
    Bizzarro A, Marra C, Acciarri A, Valenza A, Tiziano FD, Brahe C, Masullo C.
    Dement Geriatr Cogn Disord; 2005 Nov 08; 20(4):254-61. PubMed ID: 16103669
    [Abstract] [Full Text] [Related]

  • 13. Middle-aged children of persons with Alzheimer's disease: APOE genotypes and cognitive function in the Wisconsin Registry for Alzheimer's Prevention.
    Sager MA, Hermann B, La Rue A.
    J Geriatr Psychiatry Neurol; 2005 Dec 08; 18(4):245-9. PubMed ID: 16306248
    [Abstract] [Full Text] [Related]

  • 14. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.
    Lane R, Feldman HH, Meyer J, He Y, Ferris SH, Nordberg A, Darreh-Shori T, Soininen H, Pirttilä T, Farlow MR, Sfikas N, Ballard C, Greig NH.
    Pharmacogenet Genomics; 2008 Apr 08; 18(4):289-98. PubMed ID: 18334913
    [Abstract] [Full Text] [Related]

  • 15. Association between apolipoprotein E epsilon4 allele and apathy in probable Alzheimer's disease.
    Monastero R, Mariani E, Camarda C, Ingegni T, Averna MR, Senin U, Camarda R, Mecocci P.
    Acta Psychiatr Scand; 2006 Jan 08; 113(1):59-63. PubMed ID: 16390371
    [Abstract] [Full Text] [Related]

  • 16. EEG functional connectivity and ApoE genotype in Alzheimer's disease and controls.
    Kramer G, van der Flier WM, de Langen C, Blankenstein MA, Scheltens P, Stam CJ.
    Clin Neurophysiol; 2008 Dec 08; 119(12):2727-32. PubMed ID: 18848805
    [Abstract] [Full Text] [Related]

  • 17. Apolipoprotein E epsilon4, Alzheimer's disease, and cognitive performance in elderly Mexican Mestizos.
    Villalpando-Berumen JM, Mejia-Arango S, Aguilar-Salinas CA, Ordonez-Sanchez ML, Gutierrez-Robledo LM.
    J Am Geriatr Soc; 2008 Apr 08; 56(4):677-82. PubMed ID: 18205760
    [Abstract] [Full Text] [Related]

  • 18. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.
    Caselli RJ, Reiman EM, Locke DE, Hutton ML, Hentz JG, Hoffman-Snyder C, Woodruff BK, Alexander GE, Osborne D.
    Arch Neurol; 2007 Sep 08; 64(9):1306-11. PubMed ID: 17846270
    [Abstract] [Full Text] [Related]

  • 19. Reduced hippocampal volume in non-demented carriers of the apolipoprotein E epsilon4: relation to chronological age and recognition memory.
    Lind J, Larsson A, Persson J, Ingvar M, Nilsson LG, Bäckman L, Adolfsson R, Cruts M, Sleegers K, Van Broeckhoven C, Nyberg L.
    Neurosci Lett; 2006 Mar 20; 396(1):23-7. PubMed ID: 16406347
    [Abstract] [Full Text] [Related]

  • 20. Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers.
    Stonnington CM, Snyder PJ, Hentz JG, Reiman EM, Caselli RJ.
    J Clin Psychiatry; 2009 Oct 20; 70(10):1379-84. PubMed ID: 19573495
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.